scholarly journals Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary

2016 ◽  
Vol 12 (4) ◽  
pp. 384-389 ◽  
Author(s):  
Lyndsay N. Harris ◽  
Nofisat Ismaila ◽  
Lisa M. McShane ◽  
Daniel F. Hayes
Keyword(s):  
Breast Cancer ◽  
Clinical Practice ◽  
Clinical Oncology ◽  
Invasive Breast Cancer ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Systemic Therapy ◽  
Early Stage ◽  
Adjuvant Systemic Therapy ◽  
American Society

scholarly journals HER2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update Summary

2018 ◽  
Vol 14 (7) ◽  
pp. 437-441 ◽  
Author(s):  
Antonio C. Wolff ◽  
M. Elizabeth Hale Hammond ◽  
Kimberly H. Allison ◽  
Brittany E. Harvey ◽  
Lisa M. McShane ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Practice ◽  
Clinical Oncology ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Her2 Testing ◽  
American Society

scholarly journals American Society of Clinical Oncology Clinical Practice Guideline Update: Recommendations on the Role of Bone-Modifying Agents in Metastatic Breast Cancer

2011 ◽  
Vol 7 (2) ◽  
pp. 117-121 ◽  
Author(s):  
Catherine H. Van Poznak ◽  
Jamie H. Von Roenn ◽  
Sarah Temin
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Clinical Practice ◽  
Bone Metastases ◽  
Clinical Oncology ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Metastatic Breast ◽  
American Society

Journal of Clinical Oncology recently published ASCO's update to its guideline on the use of bone-modifying agents for patients with bone metastases, the scope of which was narrowed to the use of bone-modifying agents for patients with evidence of bone metastases.

Sign in / Sign up

Export Citation Format

Share Document